Clinical Trial Update: Organoid Model Predictive of Response to Immunotherapies

View source ↗

Summary

Clinical trial investigating organoid models that predict breast cancer response to immunotherapies; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Indiana University | Conditions: Breast Cancer | Status: TERMINATED